Matches in Wikidata for { <http://www.wikidata.org/entity/Q91239083> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91239083 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91239083 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91239083 description "scientific article published on 27 January 2019" @default.
- Q91239083 description "wetenschappelijk artikel" @default.
- Q91239083 description "наукова стаття, опублікована 27 січня 2019" @default.
- Q91239083 name "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 name "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 type Item @default.
- Q91239083 label "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 label "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 prefLabel "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 prefLabel "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 P1433 Q91239083-798633D4-42B9-43CB-B192-3A9C612EA762 @default.
- Q91239083 P1476 Q91239083-18C726E7-23DA-4AE2-A09E-5F95A4DB4DEF @default.
- Q91239083 P2093 Q91239083-3C1EC02B-ECE3-4592-AA8B-195D31A509AD @default.
- Q91239083 P2093 Q91239083-76E2828E-6D0F-4E60-992C-20BF18C47DCA @default.
- Q91239083 P2093 Q91239083-912FE825-1495-4310-B170-575A4461032A @default.
- Q91239083 P2093 Q91239083-C204C509-3907-47A5-B701-D896E7268B77 @default.
- Q91239083 P2093 Q91239083-E2EAF711-96E9-4BE7-8F6D-41DA8256608C @default.
- Q91239083 P2093 Q91239083-ECA97116-704A-4018-A7BF-F687499CB4B8 @default.
- Q91239083 P2093 Q91239083-FBD395B4-E358-4A72-8848-A158E18080DA @default.
- Q91239083 P304 Q91239083-3B8785C6-7FE9-4ECD-AA31-51AE2D9B990E @default.
- Q91239083 P31 Q91239083-867A52D6-9CE5-4928-A4E3-D50E36E94971 @default.
- Q91239083 P356 Q91239083-751BD0DD-D451-4725-90A4-EFD0867FE16A @default.
- Q91239083 P433 Q91239083-A1930313-C964-4F0A-A702-EAA884D1C128 @default.
- Q91239083 P478 Q91239083-0C1777FC-DCA6-477B-AF8E-D4D42722FB01 @default.
- Q91239083 P50 Q91239083-96DD192A-11B7-407B-BDA7-0B964564E9C5 @default.
- Q91239083 P577 Q91239083-38F410CE-F105-458E-A49C-CA8201F59896 @default.
- Q91239083 P698 Q91239083-CEB4E2F2-39F5-4AD3-B7BC-13C003B0C51C @default.
- Q91239083 P921 Q91239083-E00C43F3-0AB4-439D-A654-3EDC98B2410B @default.
- Q91239083 P356 S-0039-1677744 @default.
- Q91239083 P698 30685871 @default.
- Q91239083 P1433 Q15724413 @default.
- Q91239083 P1476 "Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib" @default.
- Q91239083 P2093 "Isabell Pekrul" @default.
- Q91239083 P2093 "Janina Jamasbi" @default.
- Q91239083 P2093 "Kristina Busygina" @default.
- Q91239083 P2093 "Michael Spannagl" @default.
- Q91239083 P2093 "Reinhard Lorenz" @default.
- Q91239083 P2093 "Viola Denzinger" @default.
- Q91239083 P2093 "Wolfgang Siess" @default.
- Q91239083 P304 "397-406" @default.
- Q91239083 P31 Q13442814 @default.
- Q91239083 P356 "10.1055/S-0039-1677744" @default.
- Q91239083 P433 "3" @default.
- Q91239083 P478 "119" @default.
- Q91239083 P50 Q37838769 @default.
- Q91239083 P577 "2019-01-27T00:00:00Z" @default.
- Q91239083 P698 "30685871" @default.
- Q91239083 P921 Q5984881 @default.